The concept of attacking metabolic dysfunction through multiple complementary pathways simultaneously appears to be the future direction of obesity pharmacotherapy
Because both NAC and glycine possess the unique ability to cross the blood-brain barrier, they are uniquely positioned as a therapeutic intervention to address this localized neurological deficiency
Ventricular CSF melatonin measured in animals is at least one order of magnitude higher compared to levels detected in the blood of these animals
Wagemaker MJM, Eastwood DC, Welagen J, van der Drift C, Jetten MSM, Burton K, et al
R Clinical genetics resources: PharmGKB (pharmacogenomics knowledge base): pharmgkb.org CPIC (Clinical Pharmacogenetics Implementation Consortium) guidelines for UGT1A1, NAT2, TPMT: cpicpgx.org Conjugation pathway substrates and testing: The Hepatic Detox Profile (caffeine/aspirin/acetaminophen challenge) is the gold standard functional test for Phase I/II conjugation capacity in clinical practice
Disclosures: Manpreet Virk: Nothing to Disclose, Tam Doan: Nothing to Disclose, Erik Su: Nothing to Disclose, Sanjiv Harpavat: Syneos Health: I sit on a Data Safety Monitoring Board, Nhu Thao Galvan: 3D Systems: Consultant, ASTS- Natera: Grant/Research Support, Hannah Todd: Nothing to Disclose, Lara Claudia: Nothing to Disclose, Anitha Parthiban: Nothing to Disclose, Moreshwar Desai: Nothing to Disclose 2486 TO INVESTIGATE THE ROLES OF GUT MICROBIOTA AND THEIR METABOLITES IN MODULATING THE PEDIATRIC LIVER TRANSPLANT OUTCOMES Yen-Hsuan Ni 1 Huey-Ling Chen 2 Kai-Chi Chang 1 Huey-Huey Chua 1 Fang-Wen Cheng 1 Ya-Hui Chen 1 , 1 National Taiwan University Hospital, 2 National Taiwan University Background: Liver transplantation is the last option for children with end-stage liver disease, but acute or chronic allograft rejection often occurs despite immunosuppressants and monitoring, potentially leading to graft failure
